The pain game.
Wadman
Meredith
M
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology* / Q000627:therapeutic use; D000068579:Celecoxib; D002986:Clinical Trials as Topic; D051545:Cyclooxygenase 1 / Q000378:metabolism; D051546:Cyclooxygenase 2 / Q000378:metabolism*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000191:economics / Q000494:pharmacology* / Q000627:therapeutic use; D015232:Dinoprostone / Q000096:biosynthesis / Q000378:metabolism; D017277:Drug Approval; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000191:economics; D051379:Mice; D011720:Pyrazoles / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D013449:Sulfonamides / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D013450:Sulfones / Q000009:adverse effects / Q000191:economics; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D000068579:Celecoxib; D015232:Dinoprostone